{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T06:50:16Z","timestamp":1793343016629,"version":"4.5.0"},"reference-count":68,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000066","name":"National Institute of Environmental Health Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000066","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","gynecologiconcology-online.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1016\/j.ygyno.2021.07.032","type":"journal-article","created":{"date-parts":[[2021,8,6]],"date-time":"2021-08-06T12:28:12Z","timestamp":1628252892000},"page":"199-208","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":31,"title":["Talc, body powder, and ovarian cancer: A summary of the epidemiologic evidence"],"prefix":"10.1016","volume":"163","author":[{"given":"Nicolas","family":"Wentzensen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katie M.","family":"O'Brien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ygyno.2021.07.032_bb0005","first-page":"1","article-title":"Carbon black, titanium dioxide, and talc","volume":"93","author":"IARC Working Group on the Evaluation of Carcinogenic Risks to Humans","year":"2010","journal-title":"IARC Monogr. Eval. Carcinog. Risks Hum."},{"key":"10.1016\/j.ygyno.2021.07.032_bb0010","first-page":"1","volume":"14","year":"1977","journal-title":"IARC Monogr. Eval. Carcinog. Risk Chem. Man."},{"issue":"3","key":"10.1016\/j.ygyno.2021.07.032_bb0015","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.ygyno.2016.04.011","article-title":"Talc and ovarian cancer","volume":"141","author":"Narod","year":"2016","journal-title":"Gynecol. Oncol."},{"issue":"3","key":"10.1016\/j.ygyno.2021.07.032_bb0020","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1111\/j.1471-0528.1971.tb00267.x","article-title":"Talc and carcinoma of the ovary and cervix","volume":"78","author":"Henderson","year":"1971","journal-title":"J. Obstet. Gynaecol. Br. Commonw."},{"issue":"8138","key":"10.1016\/j.ygyno.2021.07.032_bb0025","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/S0140-6736(79)90357-X","article-title":"Cosmetic talc and ovarian cancer","volume":"2","author":"Longo","year":"1979","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.ygyno.2021.07.032_bb0030","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1002\/1097-0142(19820715)50:2<372::AID-CNCR2820500235>3.0.CO;2-S","article-title":"Ovarian cancer and talc: a case-control study","volume":"50","author":"Cramer","year":"1982","journal-title":"Cancer"},{"issue":"Pt C","key":"10.1016\/j.ygyno.2021.07.032_bb0035","first-page":"11","article-title":"Arsenic, metals, fibres, and dusts","volume":"100","author":"IARC Working Group on the Evaluation of Carcinogenic Risks to Humans","year":"2012","journal-title":"IARC Monogr. Eval. Carcinog. Risks Hum."},{"issue":"2","key":"10.1016\/j.ygyno.2021.07.032_bb0040","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1080\/15287397609529432","article-title":"Consumer talcums and powders: mineral and chemical characterization","volume":"2","author":"Rohl","year":"1976","journal-title":"J. Toxicol. Environ. Health"},{"issue":"3","key":"10.1016\/j.ygyno.2021.07.032_bb0050","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/0013-9351(76)90038-4","article-title":"An examination of the fibrous mineral content of asbestos lung tissue from the Canadian chrysotile mining industry","volume":"12","author":"Pooley","year":"1976","journal-title":"Environ. Res."},{"issue":"6","key":"10.1016\/j.ygyno.2021.07.032_bb0055","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1007\/s00404-009-1030-3","article-title":"Does long-term talc exposure have a carcinogenic effect on the female genital system of rats? An experimental pilot study","volume":"280","author":"Keskin","year":"2009","journal-title":"Arch. Gynecol. Obstet."},{"issue":"5","key":"10.1016\/j.ygyno.2021.07.032_bb0060","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1093\/ajcp\/aqz080","article-title":"Migration of talc from the perineum to multiple pelvic organ sites","volume":"152","author":"McDonald","year":"2019","journal-title":"Am. J. Clin. Pathol."},{"issue":"5","key":"10.1016\/j.ygyno.2021.07.032_bb0065","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1158\/1055-9965.EPI-05-0035","article-title":"Conditions associated with antibodies against the tumor-associated antigen MUC1 and their relationship to risk for ovarian cancer","volume":"14","author":"Cramer","year":"2005","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"issue":"9","key":"10.1016\/j.ygyno.2021.07.032_bb0070","doi-asserted-by":"crossref","first-page":"2436","DOI":"10.1158\/1055-9965.EPI-08-0399","article-title":"Talc use, variants of the GSTM1, GSTT1, and NAT2 genes, and risk of epithelial ovarian cancer","volume":"17","author":"Gates","year":"2008","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"issue":"4","key":"10.1016\/j.ygyno.2021.07.032_bb0075","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/j.ajpath.2015.11.011","article-title":"The dualistic model of ovarian carcinogenesis: revisited, revised, and expanded","volume":"186","author":"Kurman","year":"2016","journal-title":"Am. J. Pathol."},{"issue":"24","key":"10.1016\/j.ygyno.2021.07.032_bb0080","doi-asserted-by":"crossref","first-page":"2888","DOI":"10.1200\/JCO.2016.66.8178","article-title":"Ovarian cancer risk factors by histologic subtype: an analysis from the ovarian cancer cohort consortium","volume":"34","author":"Wentzensen","year":"2016","journal-title":"J. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.ygyno.2021.07.032_bb0085","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1002\/path.5219","article-title":"Genomic landscape and evolutionary trajectories of ovarian cancer precursor lesions","volume":"248","author":"Wu","year":"2019","journal-title":"J. Pathol."},{"issue":"4","key":"10.1016\/j.ygyno.2021.07.032_bb0090","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1016\/j.ccell.2018.03.014","article-title":"A comprehensive pan-cancer molecular study of gynecologic and breast cancers","volume":"33","author":"Berger","year":"2018","journal-title":"Cancer Cell"},{"issue":"20","key":"10.1016\/j.ygyno.2021.07.032_bb0095","doi-asserted-by":"crossref","first-page":"2607","DOI":"10.1200\/JCO.2012.48.2596","article-title":"Type I and II endometrial cancers: have they different risk factors?","volume":"31","author":"Setiawan","year":"2013","journal-title":"J. Clin. Oncol."},{"issue":"2","key":"10.1016\/j.ygyno.2021.07.032_bb0100","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1093\/aje\/kws200","article-title":"Endometrial cancer risk factors by 2 main histologic subtypes: the NIH-AARP diet and health study","volume":"177","author":"Yang","year":"2013","journal-title":"Am. J. Epidemiol."},{"issue":"4","key":"10.1016\/j.ygyno.2021.07.032_bb0105","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1177\/096228029500400403","article-title":"Design issues in case-control studies","volume":"4","author":"Wacholder","year":"1995","journal-title":"Stat. Methods Med. Res."},{"issue":"9","key":"10.1016\/j.ygyno.2021.07.032_bb0110","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1093\/oxfordjournals.aje.a116396","article-title":"Selection of controls in case-control studies. I. Principles","volume":"135","author":"Wacholder","year":"1992","journal-title":"Am. J. Epidemiol."},{"issue":"Suppl. 1","key":"10.1016\/j.ygyno.2021.07.032_bb0115","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1080\/10408398.2010.526838","article-title":"Overview of the epidemiology methods and applications: strengths and limitations of observational study designs","volume":"50","author":"Colditz","year":"2010","journal-title":"Crit. Rev. Food Sci. Nutr."},{"issue":"2","key":"10.1016\/j.ygyno.2021.07.032_bb0120","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1158\/2159-8290.CD-12-0196","article-title":"From differences in means between cases and controls to risk stratification: a business plan for biomarker development","volume":"3","author":"Wentzensen","year":"2013","journal-title":"Cancer Discov."},{"key":"10.1016\/j.ygyno.2021.07.032_bb0125","series-title":"Oxford Textbook of Public Health","article-title":"Validity and bias in epidemiological research","author":"Greenland","year":"2009"},{"issue":"11","key":"10.1016\/j.ygyno.2021.07.032_bb0130","doi-asserted-by":"crossref","first-page":"2692","DOI":"10.1002\/ijc.33470","article-title":"Genital powder use and risk of uterine cancer: a pooled analysis of prospective studies","volume":"148","author":"O\u2019Brien","year":"2021","journal-title":"Int. J. Cancer"},{"issue":"9","key":"10.1016\/j.ygyno.2021.07.032_bb0135","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/dju260","article-title":"Talc use and ovarian cancer: epidemiology between a rock and a hard place","volume":"106","author":"Wentzensen","year":"2014","journal-title":"J. Natl. Cancer Inst."},{"issue":"10","key":"10.1016\/j.ygyno.2021.07.032_bb0140","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1158\/1055-9965.EPI-15-1281","article-title":"Association between body powder use and ovarian cancer: the African American Cancer epidemiology study (AACES)","volume":"25","author":"Schildkraut","year":"2016","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"issue":"10","key":"10.1016\/j.ygyno.2021.07.032_bb0145","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1158\/1055-9965.EPI-16-0476","article-title":"Body powder and ovarian cancer risk-what is the role of recall bias?","volume":"25","author":"Trabert","year":"2016","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"issue":"3","key":"10.1016\/j.ygyno.2021.07.032_bb0150","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1097\/CEJ.0000000000000340","article-title":"Genital use of talc and risk of ovarian cancer: a meta-analysis","volume":"27","author":"Berge","year":"2018","journal-title":"Eur. J. Cancer Prev."},{"key":"10.1016\/j.ygyno.2021.07.032_bb0155","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.reprotox.2019.08.015","article-title":"Critical review of the association between perineal use of talc powder and risk of ovarian cancer","volume":"90","author":"Kadry Taher","year":"2019","journal-title":"Reprod. Toxicol."},{"issue":"1","key":"10.1016\/j.ygyno.2021.07.032_bb0160","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1001\/jama.2019.20079","article-title":"Association of powder use in the genital area with risk of ovarian cancer","volume":"323","author":"O\u2019Brien","year":"2020","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.ygyno.2021.07.032_bb0165","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1097\/EDE.0000000000000745","article-title":"Perineal talc use and ovarian cancer: a systematic review and meta-analysis","volume":"29","author":"Penninkilampi","year":"2018","journal-title":"Epidemiology"},{"issue":"8","key":"10.1016\/j.ygyno.2021.07.032_bb0170","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1158\/1940-6207.CAPR-13-0037","article-title":"Genital powder use and risk of ovarian cancer: a pooled analysis of 8,525 cases and 9,859 controls","volume":"6","author":"Terry","year":"2013","journal-title":"Cancer Prev. Res. (Phila.)"},{"issue":"4","key":"10.1016\/j.ygyno.2021.07.032_bb0175","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1038\/bjc.1989.320","article-title":"Risk factors for ovarian cancer: a case-control study","volume":"60","author":"Booth","year":"1989","journal-title":"Br. J. Cancer"},{"issue":"12","key":"10.1016\/j.ygyno.2021.07.032_bb0180","doi-asserted-by":"crossref","first-page":"2396","DOI":"10.1002\/(SICI)1097-0142(19970615)79:12<2396::AID-CNCR15>3.0.CO;2-M","article-title":"Perineal talc exposure and risk of ovarian carcinoma","volume":"79","author":"Chang","year":"1997","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.ygyno.2021.07.032_bb0185","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1093\/ije\/21.1.23","article-title":"Risk factors for epithelial ovarian cancer in Beijing, China","volume":"21","author":"Chen","year":"1992","journal-title":"Int. J. Epidemiol."},{"issue":"5","key":"10.1016\/j.ygyno.2021.07.032_bb0190","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1093\/oxfordjournals.aje.a009128","article-title":"Perineal powder exposure and the risk of ovarian cancer","volume":"145","author":"Cook","year":"1997","journal-title":"Am. J. Epidemiol."},{"issue":"3","key":"10.1016\/j.ygyno.2021.07.032_bb0195","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1097\/EDE.0000000000000434","article-title":"The association between talc use and ovarian cancer: a retrospective case-control study in two US states","volume":"27","author":"Cramer","year":"2016","journal-title":"Epidemiology"},{"issue":"3","key":"10.1016\/j.ygyno.2021.07.032_bb0200","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1093\/jnci\/92.3.249","article-title":"Prospective study of talc use and ovarian cancer","volume":"92","author":"Gertig","year":"2000","journal-title":"J. Natl. Cancer Inst."},{"issue":"2","key":"10.1016\/j.ygyno.2021.07.032_bb0205","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/S0002-9378(98)70372-2","article-title":"Risk factors for familial and sporadic ovarian cancer among French Canadians: a case-control study","volume":"179","author":"Godard","year":"1998","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"6","key":"10.1016\/j.ygyno.2021.07.032_bb0210","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1097\/EDE.0000000000000528","article-title":"Douching, talc use, and risk of ovarian cancer","volume":"27","author":"Gonzalez","year":"2016","journal-title":"Epidemiology"},{"issue":"4","key":"10.1016\/j.ygyno.2021.07.032_bb0215","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1677\/ERC-08-0104","article-title":"Association of two common single-nucleotide polymorphisms in the CYP19A1 locus and ovarian cancer risk","volume":"15","author":"Goodman","year":"2008","journal-title":"Endocr. Relat. Cancer"},{"issue":"6","key":"10.1016\/j.ygyno.2021.07.032_bb0220","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1002\/(SICI)1097-0215(19970611)71:6<948::AID-IJC6>3.0.CO;2-Y","article-title":"Tubal sterilisation, hysterectomy and decreased risk of ovarian cancer. Survey of women\u2019s health study group","volume":"71","author":"Green","year":"1997","journal-title":"Int. J. Cancer"},{"issue":"1","key":"10.1016\/j.ygyno.2021.07.032_bb0225","first-page":"19","article-title":"Perineal exposure to talc and ovarian cancer risk","volume":"80","author":"Harlow","year":"1992","journal-title":"Obstet. Gynecol."},{"issue":"2","key":"10.1016\/j.ygyno.2021.07.032_bb0230","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1093\/oxfordjournals.aje.a115345","article-title":"A case-control study of borderline ovarian tumors: the influence of perineal exposure to talc","volume":"130","author":"Harlow","year":"1989","journal-title":"Am. J. Epidemiol."},{"issue":"14","key":"10.1016\/j.ygyno.2021.07.032_bb0235","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.1001\/jama.1983.03340140020020","article-title":"Talc and ovarian cancer","volume":"250","author":"Hartge","year":"1983","journal-title":"JAMA"},{"issue":"9","key":"10.1016\/j.ygyno.2021.07.032_bb0240","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/dju208","article-title":"Perineal powder use and risk of ovarian cancer","volume":"106","author":"Houghton","year":"2014","journal-title":"J. Natl. Cancer Inst."},{"issue":"8","key":"10.1016\/j.ygyno.2021.07.032_bb0245","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1158\/1055-9965.EPI-12-0426","article-title":"Use of fertility drugs and risk of ovarian cancer: results from a U.S.-based case-control study","volume":"21","author":"Kurta","year":"2012","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"issue":"2","key":"10.1016\/j.ygyno.2021.07.032_bb0250","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1097\/EDE.0b013e3182456ad3","article-title":"Aspirin, nonaspirin nonsteroidal anti-inflammatory drugs, or acetaminophen and risk of ovarian cancer","volume":"23","author":"Lo-Ciganic","year":"2012","journal-title":"Epidemiology"},{"issue":"1","key":"10.1016\/j.ygyno.2021.07.032_bb0255","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1002\/ijc.23017","article-title":"Talcum powder, chronic pelvic inflammation and NSAIDs in relation to risk of epithelial ovarian cancer","volume":"122","author":"Merritt","year":"2008","journal-title":"Int. J. Cancer"},{"issue":"3","key":"10.1016\/j.ygyno.2021.07.032_bb0260","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1002\/ijc.20434","article-title":"Perineal talc exposure and epithelial ovarian cancer risk in the Central Valley of California","volume":"112","author":"Mills","year":"2004","journal-title":"Int. J. Cancer"},{"issue":"5","key":"10.1016\/j.ygyno.2021.07.032_bb0265","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1093\/aje\/kwp176","article-title":"Ovarian cancer risk factors in African-American and white women","volume":"170","author":"Moorman","year":"2009","journal-title":"Am. J. Epidemiol."},{"issue":"2","key":"10.1016\/j.ygyno.2021.07.032_bb0270","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1097\/00001648-200003000-00006","article-title":"Factors related to inflammation of the ovarian epithelium and risk of ovarian cancer","volume":"11","author":"Ness","year":"2000","journal-title":"Epidemiology"},{"issue":"6","key":"10.1016\/j.ygyno.2021.07.032_bb0275","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1002\/ijc.2910620606","article-title":"Reproductive and other factors and risk of epithelial ovarian cancer: an Australian case-control study. Survey of Women\u2019s Health Study Group","volume":"62","author":"Purdie","year":"1995","journal-title":"Int. J. Cancer"},{"issue":"1","key":"10.1016\/j.ygyno.2021.07.032_bb0280","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/0090-8258(92)90485-2","article-title":"Mineral fiber exposure and the development of ovarian cancer","volume":"45","author":"Rosenblatt","year":"1992","journal-title":"Gynecol. Oncol."},{"issue":"5","key":"10.1016\/j.ygyno.2021.07.032_bb0285","first-page":"737","article-title":"Genital powder exposure and the risk of epithelial ovarian cancer","volume":"22","author":"Rosenblatt","year":"2011","journal-title":"Cancer Causes Control"},{"issue":"1","key":"10.1016\/j.ygyno.2021.07.032_bb0290","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0015-0282(16)58020-0","article-title":"Human menopausal gonadotropin and the risk of epithelial ovarian cancer","volume":"65","author":"Shushan","year":"1996","journal-title":"Fertil. Steril."},{"issue":"3","key":"10.1016\/j.ygyno.2021.07.032_bb0295","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1002\/ijc.2910550313","article-title":"Hair dyes, analgesics, tranquilizers and perineal talc application as risk factors for ovarian cancer","volume":"55","author":"Tzonou","year":"1993","journal-title":"Int. J. Cancer"},{"issue":"6","key":"10.1016\/j.ygyno.2021.07.032_bb0300","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1093\/oxfordjournals.aje.a115077","article-title":"Personal and environmental characteristics related to epithelial ovarian cancer. II. Exposures to talcum powder, tobacco, alcohol, and coffee","volume":"128","author":"Whittemore","year":"1988","journal-title":"Am. J. Epidemiol."},{"issue":"3","key":"10.1016\/j.ygyno.2021.07.032_bb0305","first-page":"372","article-title":"Perineal talc exposure and subsequent epithelial ovarian cancer: a case-control study","volume":"93","author":"Wong","year":"1999","journal-title":"Obstet. Gynecol."},{"issue":"7","key":"10.1016\/j.ygyno.2021.07.032_bb0310","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1158\/1055-9965.EPI-15-0023","article-title":"African Americans and Hispanics remain at lower risk of ovarian cancer than non-Hispanic Whites after considering nongenetic risk factors and oophorectomy rates","volume":"24","author":"Wu","year":"2015","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"10.1016\/j.ygyno.2021.07.032_bb0315","doi-asserted-by":"crossref","DOI":"10.1158\/1055-9965.EPI-21-0162","article-title":"Genital powder use and risk of epithelial ovarian cancer in the Ovarian Cancer in Women of African Ancestry Consortium","author":"Davis","year":"2021","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"issue":"3","key":"10.1016\/j.ygyno.2021.07.032_bb0320","first-page":"513","article-title":"Use of talcum powder and endometrial cancer risk","volume":"23","author":"Neill","year":"2012","journal-title":"Cancer Causes Control"},{"issue":"10","key":"10.1016\/j.ygyno.2021.07.032_bb0325","first-page":"1673","article-title":"Perineal powder use and risk of endometrial cancer in postmenopausal women","volume":"23","author":"Crawford","year":"2012","journal-title":"Cancer Causes Control"},{"issue":"5","key":"10.1016\/j.ygyno.2021.07.032_bb0330","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1158\/1055-9965.EPI-09-1221","article-title":"Perineal use of talcum powder and endometrial cancer risk","volume":"19","author":"Karageorgi","year":"2010","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"issue":"6","key":"10.1016\/j.ygyno.2021.07.032_bb0335","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1097\/EDE.0000000000001078","article-title":"Perineal talc use, douching, and the risk of uterine cancer","volume":"30","author":"O\u2019Brien","year":"2019","journal-title":"Epidemiology"},{"key":"10.1016\/j.ygyno.2021.07.032_bb0340","author":"Kelly"},{"key":"10.1016\/j.ygyno.2021.07.032_bb0345","author":"American Cancer Society"}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825821005989?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825821005989?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T03:57:31Z","timestamp":1758772651000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825821005989"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10]]},"references-count":68,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,10]]}},"alternative-id":["S0090825821005989"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2021.07.032","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2021,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Talc, body powder, and ovarian cancer: A summary of the epidemiologic evidence","name":"articletitle","label":"Article Title"},{"value":"Gynecologic Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ygyno.2021.07.032","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}